Tesla has added another small increment to its post-earnings recovery — but the defining tension of this stock remains unchanged: a market that has completely abandoned the short thesis, options traders who have turned marginally more bullish, and a price that still sits nearly 19% below where it was a month ago.
The stock closed Tuesday at $332.81, up 1.7% on the week and a fraction above the $328.58 close flagged in last Sunday's note. The incremental gain is real. What it isn't is a conviction move. The month-on-month loss is still 18.4%, and the mean analyst target of $396.62 implies roughly 19% upside from here — a gap that has barely narrowed despite two consecutive weeks of modest recovery.
The positioning picture continues to tell the same story it has since July's earnings wreckage. Short interest has slipped to a fresh 2026 low of 2.03% of the free float — down again from 2.07% and 2.08% in the two prior weekly reads. That is a continuation of the steady covering trend that has now shed roughly 11 million short shares from the mid-July peak. Borrow costs ticked up 9% on the week to 0.30%, but remain trivially cheap by any measure. Availability is entirely unconstrained — more than 1.97 billion shares available in the lending pool, far exceeding the short position. There is no mechanical squeeze pressure, and no meaningful cost deterring new shorts if sentiment were to shift. Options have moved slightly more call-heavy than usual: the put/call ratio at 0.73 is nearly a full standard deviation below its 20-day average of 0.75, a mild tilt toward optimism but nothing that reads as a directional bet. The overall positioning picture is still one of near-neutrality.
The Street's reaction to the July 22 earnings print remains the clearest structural overhang. Following a quarter that sent the stock down more than 15% in a single session and 21% over the subsequent five days, virtually every analyst who covers the name cut their price target — some dramatically. JPMorgan moved to $445 from $475, Morgan Stanley trimmed to $400 from $417, and UBS lowered to $385 from $442, all while holding their existing ratings. Only one firm, Stifel, has acted since then, cutting to $491 from $508 on August 3 while maintaining its Buy. The consensus direction post-earnings was unambiguous: targets came down, ratings held. The mean target at $396.62 still implies meaningful upside — but the bulls' confidence in the timing of that recovery has clearly diminished. The factor score picture reinforces the ambiguity. The analyst recommendation divergence score ranks in the 93rd percentile, meaning opinion is unusually split. EPS momentum scores are weak — 8th percentile on a 30-day basis, 13th on 90-day — though the 12-month forward EPS growth estimate ranks in the 71st percentile, reflecting expectations for a genuine earnings rebound further out. On valuation, the P/E at 164x and EV/EBITDA at 76x leave no margin for error if that rebound disappoints.
The bull case rests on robotaxi scale-up, energy storage growth, and autonomous driving optionality. The bear case is the one the most recent quarter validated: declining margins, intensifying EV competition, and pricing pressure eating into the cash generation needed to fund those long-term bets. Neither side has gained decisive ground since July.
The next scheduled catalyst is October 21 earnings. Between now and then, the question worth watching is whether the current modest drift higher generates enough momentum to narrow the gap to analyst targets — or whether the stock simply consolidates in the low $300s as the Street waits for evidence that the margin trough is behind it.
See the live data behind this article on ORTEX.
Open TSLA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
